吉林有专业治疗早泄的医院吗吉林包皮过长的费用需要多少,吉林治疗包皮手术大约是多少钱,吉林做包皮包茎到底要多少钱,吉林看包皮包茎医院,吉林哪家做包皮环切术医院好,吉林治早泄大概多少钱,吉林市包皮手术的费

A Virginia woman's exercise of free speech cost her a job and healthcare coverage. But she says anonymous friends online have helped lift her "heavy burdens."Juli Briskman was fired from her job on Oct. 31 after a photo of her flipping off President Trump's motorcade while riding a bicycle went viral.Last week, after the story of Briskman's termination made national news, a GoFundMe page was set up by someone who described her as "an inspiration to us all." 479

A man who police believe is the Golden State Killer will be arraigned Friday as police continue looking for more clues that connect him to the decades-old crimes.Joseph James DeAngelo, 72, was arrested Tuesday and charged with capital murder in the 1978 killing of Katie and Brian Maggiore in Sacramento County.On Thursday, FBI agents and police searched DeAngelo's home in Citrus Heights, a town about 16 miles northeast of the California capital. 456

A new US government report delivers a dire warning about climate change and its devastating impacts, saying the economy could lose hundreds of billions of dollars by the end of the century.The federally mandated study was supposed to come out in December but was released by the Trump administration on Friday, at a time when many Americans are on a long holiday weekend, distracted by family and shopping.David Easterling, director of the Technical Support Unit at the NOAA National Centers for Environmental Information, emphasized that there was "no external interference in the report's development." He added that the climate change the Earth is experiencing is unlike any other."The global average temperature is much higher and is rising more rapidly than anything modern civilization has experienced, and this warming trend can only be explained by human activities," Easterling said.Coming from the US Global Change Research Program, a team of 13 federal agencies, the Fourth National Climate Assessment was put together with the help of 1,000 people, including 300 leading scientists, roughly half from outside the government.It's the second of two volumes. The first, released in November 2017, concluded that there is "no convincing alternative explanation" for the changing climate other than "human activities, especially emissions of greenhouse gases."The report's findings run counter to President Donald Trump's consistent message that climate change is a hoax. On Wednesday, Trump tweeted, "Whatever happened to Global Warming?" as some Americans faced the coldest Thanksgiving in over a century.But the science explained in these and other federal government reports is clear: Climate change is not disproved by the extreme weather of one day or a week; it's demonstrated by long-term trends. Humans are living with the warmest temperatures in modern history. Even if the best-case scenario were to happen and greenhouse gas emissions were to drop to nothing, the world is on track to warm 1.1 degrees Fahrenheit.As of now, not a single G20 country is meeting climate targets, research shows.Without significant reductions in greenhouse emissions, the annual average global temperature could increase 9 degrees Fahrenheit (5 Celsius) or more by the end of this century, compared with preindustrial temperatures, the report says. 2355

A surge in COVID-19 cases is further straining the already-depleted supply of prescription drugs in the U.S., according to researchers and doctors at the University of Minnesota."The supply lines are really stressed and stretched," said Dr. Stephen Schondelmeyer, a co-principal investigator for the Resilient Drug Supply Project at the University of Minnesota.Schondelmeyer's work focuses on critical drugs and their supply chains. He tracks the supply chain process for every drug on the marketplace — more than 100,000 in total.Most of the prescription drugs used by Americans are made outside of the country — meaning the U.S. is reliant on foreign companies to manufacture the drug and shipping companies to deliver them safely."We're identifying where it comes from — the first thing you need to know is about 70% of all the drugs that come into the U.S. marketplace are made outside of the US.," Schondelmeyer said.He and his team want to predict and identify when and where there will be failures in the system. Right now, the U.S. has a "fail and fix" system — and right now, there are some critical breakdowns in the supply chain."Seventy-five percent of the COVID-19 drugs are currently in shortage," Schondelmeyer said. "That means three-fourths of the drugs we're using for COVID-19 were already in shortage, and that's before we had this last surge we're seeing.""We should, as a matter of national policy, have a map like we're building of the global drug supply from the beginning all the way until the drug reaches the patient," Schondelmeyer said.But it's not just COVID-19 drugs that are in short supply. Dr. Beth Thielen, an assistant professor of pediatrics at the University of Minnesota Medical School and an infectious disease physician, says even some routine drugs are hard to come by."As a physician working in the hospital — the University of Minnesota — we're a big urban center and yet we're regularly dealing with this issue of shortages in routine things like antibiotics," Thielen said. "It's very concerning to think about the supply chain breaking down and seeing drugs not available in pharmacies or the hospital."Doctors say COVID-19 has unmasked a problem that's been a concern for decades. The pharmaceutical supply chain is complicated and dependent on other countries — and there are supply and demand dilemmas."Start the conversation now with your healthcare provider," Thielen said. "There might be some within class substitutions of medicines, so a drug that is related may not be the exact same drug but might fulfill the same purpose."Schondelmeyer adds that anyone with a regular prescription should ask their doctor about getting a 90-day supply of essential drugs — but adds that there's no reason to hoard medication."We shouldn't panic. We shouldn't treat drugs like we did toilet paper and stock up on so much that we're totally out — and that's an example of what can happen when there's rumors of shortages," Schondelmeyer said. "People act out of fear, and they hoard more than they really need."In the meantime, Schondelmeyer is pushing for a national stockpile of critical medications, so that the U.S. is covered should there be a complete breakdown in the supply chain. 3236

A new medical device promises to diagnose a concussion in under four minutes and its creators are backed by a unique partnership between the NFL's Green Bay Packers and Microsoft.The world of traumatic brain injuries and concussions is filled with gray matter. The diagnosis is subjective and every doctor manages it differently as the injury is just as complex as the brain.“When you have a heart attack and go into the ER, you get five objective tests. If you get a brain injury and you go into the ER, you get, ‘Follow my finger, what month is it, who’s the president?’ We have to do better for brain-injured patients,” Dr. Rosina Samadani, CEO of Oculogica, said.Samadani developed a device called the "Eye Box.” Her sister, a neurosurgeon, discovered the technology.“Where it really came from was noticing that when there’s a deficit in the cranial nerves, there is a deficit in eye movements and there is that same deficit that occurs in concussed patients.,” Samadani said.So, she created an algorithm based on those eye movements, which is how the Eye Box was born.“We’re looking at your pupils, we’re tracking them and having you perform a simple task,” Samadani said. “You watch a video as it moves around the screen and we watch your eyes watching that video and that’s it.”The sisters took the idea to TitletownTech.“We look for exceptional founders who are solving meaningful problem,” said Jill Enos, the managing director of TitletownTech.The venture capital fund builds and invests in startups.“TitletownTech was formed out of this improbable partnership between the Green Bay packers and Microsoft, both of whom shared a common interest in advancing the technology capabilities of the region but also in leveraging the strength of startups and founders as economic drivers in the regional economy,” Enos said.Enos says Oculogica immediately caught their attention. And that is no easy feat. In just 15 months, more than a thousand ideas have crossed their desk. They've invested in 20; several are women and minority led.“As someone who is in venture capital, which is also not a very common women focused industry, it was great to see two strong founders that we could connect with and get behind,” says Enos.“We don’t feel that we’re so different than our peers but we are. We know we are and with that, we feel there is a great deal of responsibility,” Samadani said.She wants girls to love math and science like she does. And she says to realize that the sky is the limit.“We’re also very excited to show other women and young girls they can do this and women can be great at math and science. I wake up every single day and I’m so excited about what I’m doing and we’re changing the world of brain injury. Any woman, any young girl, can grow up to do this and that’s fantastic,” said Samadani.Oculogica is already authorized by the FDA, and the insurance and reimbursement codes are being worked out now. Some clinics already have it, and more are expected.“The best feeling is when we get a call from a mom or dad who says, ‘I'm so relieved we now know what’s going on,'” Samadani said. "'I didn’t know where to turn it.’ Just relieves their anxiety that is everything- absolutely everything when we get a call like that.” 3253